TRIM67
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| tripartite motif containing 67 | MIM:610584 | Ensembl:ENSG00000119283 | HGNC:HGNC:31859 | PA134947738 | 1q42.2 |
GO terms in TRIM67
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IEA | GO:0008270 | zinc ion binding |
| BP | IEA | GO:0010976 | positive regulation of neuron projection development |
| BP | IEA | GO:0046580 | negative regulation of Ras protein signal transduction |
| BP | ISS | GO:1903827 | regulation of cellular protein localization |
| BP | IEA | GO:2000060 | positive regulation of ubiquitin-dependent protein catabolic process |
| CC | IEA | GO:0005737 | cytoplasm |
| CC | IEA | GO:0005856 | cytoskeleton |
Gene expression in normal tissue: TRIM67
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in TRIM67
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD121 | GMX1778 | 3 |
| iGMDRD158 | NSC141540 | 3 |
| iGMDRD137 | Indisulam | 6 |
| iGMDRD103 | SN-38 | 3 |
| iGMDRD309 | 17AAG | 1 |
| iGMDRD187 | BRD9876 | 3 |
| iGMDRD481 | Dactolisib | 2 |
| iGMDRD441 | TW 37 | 3 |
| iGMDRD379 | BIBR-1532 | 3 |
| iGMDRD888 | Compound 44 | 2 |
| iGMDRD329 | Merck60 | 3 |
| iGMDRD887 | Compound 23 citrate | 2 |
| iGMDRD286 | Nsc 632839 | 3 |
| iGMDRD188 | Piperlongumine | 1 |
| iGMDRD554 | CHEMBL1434137 | 6 |
| iGMDRD433 | Lexibulin | 2 |
| iGMDRD523 | Cyanoquinoline, 11 | 3 |
| iGMDRD116 | CD437 | 3 |
| iGMDRD61 | Kinetin riboside | 5 |
| iGMDRD639 | YK 4-279 | 2 |
| iGMDRD57 | Chloropentafluorobenzene | 2 |
| iGMDRD351 | GW843682X | 3 |
| iGMDRD341 | Triacsin c | 3 |
| iGMDRD446 | LY 2183240 | 3 |
| iGMDRD177 | Teniposide | 3 |
| iGMDRD211 | (1S,3R)-RSL3 | 2 |
| iGMDRD901 | ELCPK | 3 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in TRIM67

